ArticleActa neuropathologica communications2026
LncRNA-HLX-2-7/HLX axis-dependent metabolic reprogramming drives cancer progression in group 3 medulloblastoma.
Keisuke Katsushima et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.